Pharmacists to claim due compensation for Zyprexa business loss.

The government reduced the NHI prices of Zyprexa (Olanzapine: anti-psychotic drug) by 14 to 39.9% as of Dec. 1 after its prescription being reclassified from a drug of the 2nd choice to of the first choice, which eventually brought out a business loss to the pharmacies in the market. However, E. Lilly Korea declined to accept the compensation package including the return of stocks raised by th...